Pancreatic Cancer Research

ResearcherKumamoto UniversityActive in the last 2 years

Takanobu Yamao

Matched on ORCID iD 0000-0003-3125-9165; OpenAlex author ID A5025877176. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2018: 3 papers · 2019: 2 papers · 2020: 4 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 3 papers

Papers 15

  1. Preoperative Total Iron-Binding Capacity Is a Potential Surrogate Marker of Long-Term Outcomes After Pancreatectomy for Pancreatic Cancer. Co-author DOI 10.1002/ags3.70297↗
  2. A case of long-term survival in unresectable pancreatic cancer with BRCA germline mutation treated with platinum-based chemotherapy. Co-author DOI 10.1007/s12328-026-02359-4↗
  3. Evaluation of Claudin 18.2 Expression Changes Following Chemotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.18442↗
  4. Emergency rectal obstruction caused by pancreatic cancer metastasizing to the rectum. First author DOI 10.1007/s12328-025-02194-z↗
  5. Molecular Alterations Influencing the Prognostic Outcome in Small Pancreatic Cancer (≤2 cm). Co-author DOI 10.1097/mpa.0000000000002430↗
  6. Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Institution Study. Co-author DOI 10.1245/s10434-020-09022-3↗
  7. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients underg… Co-author DOI 10.1007/s00595-019-01866-x↗
  8. Successful Treatment for the Recurrent Liver Metastases of the Pancreatic Cancer by Multimodality Therapy. Co-author DOI 10.1097/mpa.0000000000001622↗
  9. Efficacy of Staging Laparoscopy for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.14037↗
  10. Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/invivo.12111↗
  11. PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis. Co-author DOI 10.1111/cas.13874↗
  12. Cellular Senescence, Represented by Expression of Caveolin-1, in Cancer-Associated Fibroblasts Promotes Tumor Invasion in Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07266-2↗
  13. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2017.08.016↗
  14. Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Unde… Co-author DOI 10.1097/mpa.0000000000001146↗
  15. Cystic gastric metastasis from pancreatic cancer. Co-author DOI 10.1186/s40792-018-0443-2↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiromitsu Hayashi · 9 shared papers, 2019–2026 · strength 1.61
  2. Yuki Kitano · 9 shared papers, 2018–2026 · strength 1.51
  3. Hirohisa Okabe · 9 shared papers, 2018–2026 · strength 1.38
  4. Tatsunori Miyata · 8 shared papers, 2018–2026 · strength 1.09
  5. Shigeki Nakagawa · 7 shared papers, 2018–2026 · strength 0.92
  6. Masaaki Iwatsuki · 3 shared papers, 2026 · strength 0.86
  7. Katsunori Imai · 8 shared papers, 2018–2021 · strength 0.73
  8. Toru Takematsu · 3 shared papers, 2020–2026 · strength 0.64
  9. Rumi Itoyama · 4 shared papers, 2020–2026 · strength 0.60
  10. Yosuke Nakao · 4 shared papers, 2019–2025 · strength 0.55
  11. Masayo Tsukamoto · 6 shared papers, 2018–2021 · strength 0.52
  12. Akira Chikamoto · 6 shared papers, 2018–2021 · strength 0.50
  13. Kensuke Yamamura · 5 shared papers, 2018–2020 · strength 0.44
  14. Kota Arima · 5 shared papers, 2018–2020 · strength 0.41
  15. Naoki Umezaki · 5 shared papers, 2018–2020 · strength 0.39
  16. Hideo Andreas Baba · 2 shared papers, 2021–2025 · strength 0.36
  17. Hideo Baba · 4 shared papers, 2019–2020 · strength 0.36
  18. Kunitaka Kuramoto · 1 shared paper, 2025 · strength 0.33
  19. Takuya Shimogawa · 1 shared paper, 2025 · strength 0.33
  20. Daisuke Hashimoto · 4 shared papers, 2018–2020 · strength 0.32
  21. Keita Takahashi · 1 shared paper, 2026 · strength 0.29
  22. Takashi Matsumoto · 1 shared paper, 2026 · strength 0.29
  23. Taishi Yamane · 1 shared paper, 2026 · strength 0.29
  24. Hiroki Tsubakihara · 1 shared paper, 2026 · strength 0.28
  25. Shinsei Yumoto · 1 shared paper, 2026 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.